Beyond enhancing utilization and controlling costs, smarter diagnostic management is unlocking new opportunities for health equity and innovation. In this article, Avalon CEO Dr. Bill Kerr, MD, explains how using diagnostic data at scale allows health plans to identify care gaps, recognize disparities, and ensure that all members regardless of geography or income—have timely access to essential testing.
Dr. Kerr highlights that the next frontier of LBM involves data integration and predictive analytics, which help plans turn lab results into actionable population health insights. This shift transforms diagnostics from a transactional task into a strategic tool for prevention and precision medicine.
Read the full article at Healthcare Business Today.
